Maggioni AP - Search Results

1

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Senni M, Paulus WJ, Gavazzi A, Fraser AG, Díez J, Solomon SD, Smiseth OA, Guazzi M, Lam CS, Maggioni AP, Tschöpe C, Metra M, Hummel SL, Edelmann F, Ambrosio G, Stewart Coats AJ, Filippatos GS, Gheorghiade M, Anker SD, Levy D, Pfeffer MA, Stough WG, Pieske BM. Senni M, et al. Among authors: maggioni ap. Eur Heart J. 2014 Oct 21;35(40):2797-815. doi: 10.1093/eurheartj/ehu204. Epub 2014 Aug 7. Eur Heart J. 2014. PMID: 25104786 Free PMC article. Review.

2

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.

McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs R, Maggioni A, Pina I, Soler-Soler J, Swedberg K; Clinical Research Initiative in Heart failure. McMurray J, et al. Eur J Heart Fail. 2001 Aug;3(4):495-502. doi: 10.1016/s1388-9842(01)00173-8. Eur J Heart Fail. 2001. PMID: 11511437 Free article.

3

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F, Porcu M, Scherillo M, Opasich C, Di Lenarda A, Senni M, Maggioni AP; IN-CHF Investigators. Pulignano G, et al. Among authors: maggioni ap. Am Heart J. 2002 Jan;143(1):45-55. doi: 10.1067/mhj.2002.119608. Am Heart J. 2002. PMID: 11773911

4

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

Maggioni AP, Anand I, Gottlieb SO, Latini R, Tognoni G, Cohn JN; Val-HeFT Investigators (Valsartan Heart Failure Trial). Maggioni AP, et al. J Am Coll Cardiol. 2002 Oct 16;40(8):1414-21. doi: 10.1016/s0735-1097(02)02304-5. J Am Coll Cardiol. 2002. PMID: 12392830 Free article.

5

Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.

Tarantini L, Faggiano P, Senni M, Lucci D, Bertoli D, Porcu M, Opasich C, Tavazzi L, Maggioni AP. Tarantini L, et al. Among authors: maggioni ap. Ital Heart J. 2002 Nov;3(11):656-64. Ital Heart J. 2002. PMID: 12506524

6

Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors.

Porcu M, Opasich C, Scherillo M, Lucci D, De Maria R, Di Tano G, Maggioni AP; Italian Network on Congestive Heart Failure (IN-CHF) Investigators. Porcu M, et al. Among authors: maggioni ap. Ital Heart J. 2002 Dec;3(12):730-7. Ital Heart J. 2002. PMID: 12611125

7

Prescription patterns of diuretics in chronic heart failure: a contemporary background as a clue to their role in treatment.

Faggiano P, Opasich C, Tavazzi L, Achilli F, Gentile A, De Biase L, De Maria R, Pozzi R, Tarantini L, Gonzini L, Maggioni AP; IN-CHF Investigators. Faggiano P, et al. Among authors: maggioni ap. J Card Fail. 2003 Jun;9(3):210-8. doi: 10.1054/jcaf.2003.25. J Card Fail. 2003. PMID: 12815571

8

VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.

Velazquez EJ, Pfeffer MA, McMurray JV, Maggioni AP, Rouleau JL, Van de Werf F, Kober L, White HD, Swedberg K, Leimberger JD, Gallo P, Sellers MA, Edwards S, Henis M, Califf RM; VALIANT Investigators. Velazquez EJ, et al. Among authors: maggioni ap. Eur J Heart Fail. 2003 Aug;5(4):537-44. doi: 10.1016/s1388-9842(03)00112-0. Eur J Heart Fail. 2003. PMID: 12921816 Free article.

9

Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.

McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, Held P, Yusuf S. McKelvie RS, et al. Among authors: maggioni ap. Eur Heart J. 2003 Oct;24(19):1727-34. doi: 10.1016/s0195-668x(03)00477-9. Eur Heart J. 2003. PMID: 14522567 Clinical Trial.

10

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators. Pfeffer MA, et al. Among authors: maggioni ap. N Engl J Med. 2003 Nov 13;349(20):1893-906. doi: 10.1056/NEJMoa032292. Epub 2003 Nov 10. N Engl J Med. 2003. PMID: 14610160 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

968 results

Search Page